Trial Outcomes & Findings for COMMunication and Education for the New CPAP Experience (NCT NCT01377584)

NCT ID: NCT01377584

Last Updated: 2017-10-02

Results Overview

The Epworth Sleepiness Scale is an 8-item questionnaire that assesses daytime sleepiness.Total scores range from 0 to 24. A score of \> 10 indicates excessive daytime sleepiness.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

60 participants

Primary outcome timeframe

baseline and 3 months after CPAP initiation

Results posted on

2017-10-02

Participant Flow

Participant milestones

Participant milestones
Measure
Patients in the Couple-oriented Intervention
Patients randomly assigned to the couple-oriented (CO) group will attend two face to face sessions and participate in an individual telephone follow-up session. Couple-oriented intervention: The first session will occur before the patient receives his/her CPAP. This session will provide the couple with education on sleep apnea and CPAP, demonstration of PAP equipment, explore patient's concerns about starting CPAP treatment, and provide a goal setting exercise. The second face to face session will occur one week after the patient receives his/her CPAP. The second session will provide the couple with information on CPAP usage and pre- and post-treatment AHI, explore barriers to CPAP use and benefits of CPAP use, and provide a goal setting exercise. The individual telephone follow-up sessions will occur two weeks after the patient has received his/her CPAP. This session will review CPAP usage and explore barriers and facilitators of CPAP use.
Partners in the Couple-oriented Intervention
Partners randomly assigned to the couple-oriented (CO) group will attend two face to face sessions with the patient and participate in an individual telephone follow-up session.
Patients in the Patient-oriented Intervention
Patients randomly assigned to the patient-oriented (PT) group will attend two face to face sessions and participate in a telephone follow-up session. Patient-oriented intervention: The first session will occur before the patient receives his/her CPAP. This session will provide the patient with education on sleep apnea and CPAP, demonstration of PAP equipment, explore patient's concerns about starting CPAP treatment, and provide a goal setting exercise. The second face to face session will occur one week after the patient receives his/her CPAP. The second session will provide the patient with information on CPAP usage and pre- and post-treatment AHI, explore barriers to CPAP use and benefits of CPAP use, and provide a goal setting exercise. The telephone follow-up sessions will occur two weeks after the patient has received his/her CPAP. This session will review CPAP usage and explore barriers and facilitators of CPAP use.
Partners in the Patient-oriented Intervention
Partners randomly assigned to the patient-oriented (PT) group will not attend any intervention sessions.
Patients in Usual Care
Patients will not attend any intervention sessions.
Partners in Usual Care
Partners will not attend any intervention sessions.
Overall Study
STARTED
8
8
10
10
12
12
Overall Study
COMPLETED
5
5
6
6
9
9
Overall Study
NOT COMPLETED
3
3
4
4
3
3

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

COMMunication and Education for the New CPAP Experience

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Patients in the Couple-oriented Intervention
n=5 Participants
Patients randomly assigned to the couple-oriented (CO) group will attend two face to face sessions and participate in an individual telephone follow-up session. Couple-oriented intervention: The first session will occur before the patient receives his/her CPAP. This session will provide the couple with education on sleep apnea and CPAP, demonstration of PAP equipment, explore patient's concerns about starting CPAP treatment, and provide a goal setting exercise. The second face to face session will occur one week after the patient receives his/her CPAP. The second session will provide the couple with information on CPAP usage and pre- and post-treatment AHI, explore barriers to CPAP use and benefits of CPAP use, and provide a goal setting exercise. The individual telephone follow-up sessions will occur two weeks after the patient has received his/her CPAP. This session will review CPAP usage and explore barriers and facilitators of CPAP use.
Partners in the Couple-oriented Intervention
n=5 Participants
Partners randomly assigned to the couple-oriented (CO) group will attend two face to face sessions with the patient and participate in an individual telephone follow-up session.
Patients in the Patient-oriented Intervention
n=6 Participants
Patients randomly assigned to the patient-oriented (PT) group will attend two face to face sessions and participate in a telephone follow-up session. Patient-oriented intervention: The first session will occur before the patient receives his/her CPAP. This session will provide the patient with education on sleep apnea and CPAP, demonstration of PAP equipment, explore patient's concerns about starting CPAP treatment, and provide a goal setting exercise. The second face to face session will occur one week after the patient receives his/her CPAP. The second session will provide the patient with information on CPAP usage and pre- and post-treatment AHI, explore barriers to CPAP use and benefits of CPAP use, and provide a goal setting exercise. The telephone follow-up sessions will occur two weeks after the patient has received his/her CPAP. This session will review CPAP usage and explore barriers and facilitators of CPAP use.
Partners in the Patient-oriented Intervention
n=6 Participants
Partners randomly assigned to the patient-oriented (PT) group will not attend any intervention sessions.
Patients in Usual Care
n=9 Participants
Patients will not attend any intervention sessions.
Partners in Usual Care
n=9 Participants
Partners will not attend any intervention sessions
Total
n=40 Participants
Total of all reporting groups
Age, Continuous
49 years
STANDARD_DEVIATION 14 • n=5 Participants
43 years
STANDARD_DEVIATION 3 • n=7 Participants
50 years
STANDARD_DEVIATION 11 • n=5 Participants
54 years
STANDARD_DEVIATION 14 • n=4 Participants
54 years
STANDARD_DEVIATION 7 • n=21 Participants
54 years
STANDARD_DEVIATION 7 • n=8 Participants
52 years
STANDARD_DEVIATION 10 • n=8 Participants
Sex: Female, Male
Female
1 Participants
n=5 Participants
4 Participants
n=7 Participants
2 Participants
n=5 Participants
3 Participants
n=4 Participants
3 Participants
n=21 Participants
6 Participants
n=8 Participants
19 Participants
n=8 Participants
Sex: Female, Male
Male
4 Participants
n=5 Participants
1 Participants
n=7 Participants
4 Participants
n=5 Participants
3 Participants
n=4 Participants
6 Participants
n=21 Participants
3 Participants
n=8 Participants
21 Participants
n=8 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
0 Participants
n=8 Participants
0 Participants
n=8 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
0 Participants
n=8 Participants
0 Participants
n=8 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
0 Participants
n=8 Participants
0 Participants
n=8 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants
3 Participants
n=4 Participants
3 Participants
n=21 Participants
4 Participants
n=8 Participants
12 Participants
n=8 Participants
Race (NIH/OMB)
White
5 Participants
n=5 Participants
5 Participants
n=7 Participants
3 Participants
n=5 Participants
2 Participants
n=4 Participants
5 Participants
n=21 Participants
3 Participants
n=8 Participants
23 Participants
n=8 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
1 Participants
n=4 Participants
1 Participants
n=21 Participants
2 Participants
n=8 Participants
5 Participants
n=8 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
0 Participants
n=8 Participants
0 Participants
n=8 Participants
Apnea-Hypopnea Index
40 Events per hour of sleep
STANDARD_DEVIATION 40 • n=5 Participants
NA Events per hour of sleep
STANDARD_DEVIATION NA • n=7 Participants
30 Events per hour of sleep
STANDARD_DEVIATION 32 • n=5 Participants
NA Events per hour of sleep
STANDARD_DEVIATION NA • n=4 Participants
40 Events per hour of sleep
STANDARD_DEVIATION 28 • n=21 Participants
NA Events per hour of sleep
STANDARD_DEVIATION NA • n=8 Participants
37 Events per hour of sleep
STANDARD_DEVIATION 31 • n=8 Participants

PRIMARY outcome

Timeframe: baseline and 3 months after CPAP initiation

The Epworth Sleepiness Scale is an 8-item questionnaire that assesses daytime sleepiness.Total scores range from 0 to 24. A score of \> 10 indicates excessive daytime sleepiness.

Outcome measures

Outcome measures
Measure
Patients in the Couple-oriented Intervention
n=5 Participants
Patients randomly assigned to the couple-oriented (CO) group will attend two face to face sessions and participate in an individual telephone follow-up session. Couple-oriented intervention: The first session will occur before the patient receives his/her CPAP. This session will provide the couple with education on sleep apnea and CPAP, demonstration of PAP equipment, explore patient's concerns about starting CPAP treatment, and provide a goal setting exercise. The second face to face session will occur one week after the patient receives his/her CPAP. The second session will provide the couple with information on CPAP usage and pre- and post-treatment AHI, explore barriers to CPAP use and benefits of CPAP use, and provide a goal setting exercise. The individual telephone follow-up sessions will occur two weeks after the patient has received his/her CPAP. This session will review CPAP usage and explore barriers and facilitators of CPAP use.
Partners in the Couple-oriented Intervention
n=5 Participants
Partners randomly assigned to the couple-oriented (CO) group will attend two face to face sessions with the patient and participate in an individual telephone follow-up session.
Patients in the Patient-oriented Intervention
n=6 Participants
Patients randomly assigned to the patient-oriented (PT) group will attend two face to face sessions and participate in a telephone follow-up session. Patient-oriented intervention: The first session will occur before the patient receives his/her CPAP. This session will provide the patient with education on sleep apnea and CPAP, demonstration of PAP equipment, explore patient's concerns about starting CPAP treatment, and provide a goal setting exercise. The second face to face session will occur one week after the patient receives his/her CPAP. The second session will provide the patient with information on CPAP usage and pre- and post-treatment AHI, explore barriers to CPAP use and benefits of CPAP use, and provide a goal setting exercise. The telephone follow-up sessions will occur two weeks after the patient has received his/her CPAP. This session will review CPAP usage and explore barriers and facilitators of CPAP use.
Partners in the Patient-oriented Intervention
n=6 Participants
Partners randomly assigned to the patient-oriented (PT) group will not attend any intervention sessions.
Patients in Usual Care
n=9 Participants
Patients will not attend any intervention sessions.
Partners in Usual Care
n=9 Participants
Partners will not attend any intervention sessions.
Daytime Sleepiness
Baseline
9.0 units on a scale
Standard Deviation 6.9
3.8 units on a scale
Standard Deviation 1.9
6.8 units on a scale
Standard Deviation 6.8
6.5 units on a scale
Standard Deviation 4.6
10.8 units on a scale
Standard Deviation 5.9
7.3 units on a scale
Standard Deviation 5.2
Daytime Sleepiness
3 month follow-up
4.2 units on a scale
Standard Deviation 0.8
1.5 units on a scale
Standard Deviation 2.5
3.3 units on a scale
Standard Deviation 2.1
6.9 units on a scale
Standard Deviation 4.5
6.4 units on a scale
Standard Deviation 4.8
4.7 units on a scale
Standard Deviation 3.4
Daytime Sleepiness
Change from Baseline to 3 months
-4.8 units on a scale
Standard Deviation 0.8
-1.8 units on a scale
Standard Deviation 1.0
-3.5 units on a scale
Standard Deviation 6.7
0.4 units on a scale
Standard Deviation 4.2
-4.3 units on a scale
Standard Deviation 4.6
-2.7 units on a scale
Standard Deviation 3.1

PRIMARY outcome

Timeframe: baseline and 3 months after CPAP initiation

The Functional Outcomes of Sleep Questionnaire-10 is 10-item questionnaire assesses the impact of sleep disorders of excessive sleepiness on multiple activities of everyday living. Scores for five domains of functioning (e.g., activity, vigilance, intimacy and sexual relationships, general productivity, and social outcome) are obtained. Each domain score ranges from 1 to 4 (1 indicating more difficulty). The total score is derived by calculating the mean of the domain scores and multiplying by five. The total score ranges from 5 to 20, with higher scores indicating greater functioning.

Outcome measures

Outcome measures
Measure
Patients in the Couple-oriented Intervention
n=5 Participants
Patients randomly assigned to the couple-oriented (CO) group will attend two face to face sessions and participate in an individual telephone follow-up session. Couple-oriented intervention: The first session will occur before the patient receives his/her CPAP. This session will provide the couple with education on sleep apnea and CPAP, demonstration of PAP equipment, explore patient's concerns about starting CPAP treatment, and provide a goal setting exercise. The second face to face session will occur one week after the patient receives his/her CPAP. The second session will provide the couple with information on CPAP usage and pre- and post-treatment AHI, explore barriers to CPAP use and benefits of CPAP use, and provide a goal setting exercise. The individual telephone follow-up sessions will occur two weeks after the patient has received his/her CPAP. This session will review CPAP usage and explore barriers and facilitators of CPAP use.
Partners in the Couple-oriented Intervention
n=5 Participants
Partners randomly assigned to the couple-oriented (CO) group will attend two face to face sessions with the patient and participate in an individual telephone follow-up session.
Patients in the Patient-oriented Intervention
n=6 Participants
Patients randomly assigned to the patient-oriented (PT) group will attend two face to face sessions and participate in a telephone follow-up session. Patient-oriented intervention: The first session will occur before the patient receives his/her CPAP. This session will provide the patient with education on sleep apnea and CPAP, demonstration of PAP equipment, explore patient's concerns about starting CPAP treatment, and provide a goal setting exercise. The second face to face session will occur one week after the patient receives his/her CPAP. The second session will provide the patient with information on CPAP usage and pre- and post-treatment AHI, explore barriers to CPAP use and benefits of CPAP use, and provide a goal setting exercise. The telephone follow-up sessions will occur two weeks after the patient has received his/her CPAP. This session will review CPAP usage and explore barriers and facilitators of CPAP use.
Partners in the Patient-oriented Intervention
n=6 Participants
Partners randomly assigned to the patient-oriented (PT) group will not attend any intervention sessions.
Patients in Usual Care
n=9 Participants
Patients will not attend any intervention sessions.
Partners in Usual Care
n=9 Participants
Partners will not attend any intervention sessions.
Sleep-related Functional Outcomes
Baseline
16.6 units on a scale
Standard Deviation 2.6
16.7 units on a scale
Standard Deviation 2.6
17.2 units on a scale
Standard Deviation 3.3
16.9 units on a scale
Standard Deviation 3.9
15.6 units on a scale
Standard Deviation 4.3
17.3 units on a scale
Standard Deviation 2.4
Sleep-related Functional Outcomes
3 month follow-up
17.9 units on a scale
Standard Deviation 0.9
18.2 units on a scale
Standard Deviation 2.1
19.1 units on a scale
Standard Deviation 1.5
17.3 units on a scale
Standard Deviation 2.9
17.7 units on a scale
Standard Deviation 2.8
18.0 units on a scale
Standard Deviation 1.6
Sleep-related Functional Outcomes
Change from Baseline to 3 months
2.1 units on a scale
Standard Deviation 3.0
1.5 units on a scale
Standard Deviation 0.7
1.9 units on a scale
Standard Deviation 3.7
0.0 units on a scale
Standard Deviation 1.8
2.1 units on a scale
Standard Deviation 3.3
0.8 units on a scale
Standard Deviation 1.1

PRIMARY outcome

Timeframe: baseline and 3 months after CPAP initiation

The Pittsburgh Sleep Quality Index (PSQI) is a 19 item questionnaire that measures self-reported sleep quality and disturbances over the last 1 month time period. The questionnaire measures 7 components of sleep quality: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. A global PSQI score is obtained by summing the 7 component scores (range = 0-21). A PSQI global score \> 5 indicates a poor sleeper.

Outcome measures

Outcome measures
Measure
Patients in the Couple-oriented Intervention
n=5 Participants
Patients randomly assigned to the couple-oriented (CO) group will attend two face to face sessions and participate in an individual telephone follow-up session. Couple-oriented intervention: The first session will occur before the patient receives his/her CPAP. This session will provide the couple with education on sleep apnea and CPAP, demonstration of PAP equipment, explore patient's concerns about starting CPAP treatment, and provide a goal setting exercise. The second face to face session will occur one week after the patient receives his/her CPAP. The second session will provide the couple with information on CPAP usage and pre- and post-treatment AHI, explore barriers to CPAP use and benefits of CPAP use, and provide a goal setting exercise. The individual telephone follow-up sessions will occur two weeks after the patient has received his/her CPAP. This session will review CPAP usage and explore barriers and facilitators of CPAP use.
Partners in the Couple-oriented Intervention
n=5 Participants
Partners randomly assigned to the couple-oriented (CO) group will attend two face to face sessions with the patient and participate in an individual telephone follow-up session.
Patients in the Patient-oriented Intervention
n=6 Participants
Patients randomly assigned to the patient-oriented (PT) group will attend two face to face sessions and participate in a telephone follow-up session. Patient-oriented intervention: The first session will occur before the patient receives his/her CPAP. This session will provide the patient with education on sleep apnea and CPAP, demonstration of PAP equipment, explore patient's concerns about starting CPAP treatment, and provide a goal setting exercise. The second face to face session will occur one week after the patient receives his/her CPAP. The second session will provide the patient with information on CPAP usage and pre- and post-treatment AHI, explore barriers to CPAP use and benefits of CPAP use, and provide a goal setting exercise. The telephone follow-up sessions will occur two weeks after the patient has received his/her CPAP. This session will review CPAP usage and explore barriers and facilitators of CPAP use.
Partners in the Patient-oriented Intervention
n=6 Participants
Partners randomly assigned to the patient-oriented (PT) group will not attend any intervention sessions.
Patients in Usual Care
n=9 Participants
Patients will not attend any intervention sessions.
Partners in Usual Care
n=9 Participants
Partners will not attend any intervention sessions.
Sleep Quality
Baseline
8.4 units on a scale
Standard Deviation 2.5
7.0 units on a scale
Standard Deviation 2.9
7.8 units on a scale
Standard Deviation 3.1
7.2 units on a scale
Standard Deviation 2.1
8.3 units on a scale
Standard Deviation 4.5
9.9 units on a scale
Standard Deviation 3.0
Sleep Quality
3 month follow-up
5.0 units on a scale
Standard Deviation 3.4
6.4 units on a scale
Standard Deviation 5.0
5.8 units on a scale
Standard Deviation 3.7
7.4 units on a scale
Standard Deviation 3.7
6.1 units on a scale
Standard Deviation 5.8
7.3 units on a scale
Standard Deviation 2.8
Sleep Quality
Change from Baseline to 3 months
-4.3 units on a scale
Standard Deviation 3.1
-1.5 units on a scale
Standard Deviation 3.5
-2.0 units on a scale
Standard Deviation 1.7
-1.8 units on a scale
Standard Deviation 2.2
-2.2 units on a scale
Standard Deviation 4.9
-2.7 units on a scale
Standard Deviation 4.4

SECONDARY outcome

Timeframe: one week, one month, and 3 months after CPAP initiation

Adherence will be measured as the amount of time that the CPAP machine is turned on and maintained at prescribed pressure. The latter number represents the amount of time power is on and the mask is positioned properly on the face. All patients will be using a CPAP machine with remote monitoring capabilities. Adherence reports are automatically uploaded to a secure data center daily. Adherence data can be accessed through the web-based patient compliance management system, EncoreAnywhere.

Outcome measures

Outcome measures
Measure
Patients in the Couple-oriented Intervention
n=5 Participants
Patients randomly assigned to the couple-oriented (CO) group will attend two face to face sessions and participate in an individual telephone follow-up session. Couple-oriented intervention: The first session will occur before the patient receives his/her CPAP. This session will provide the couple with education on sleep apnea and CPAP, demonstration of PAP equipment, explore patient's concerns about starting CPAP treatment, and provide a goal setting exercise. The second face to face session will occur one week after the patient receives his/her CPAP. The second session will provide the couple with information on CPAP usage and pre- and post-treatment AHI, explore barriers to CPAP use and benefits of CPAP use, and provide a goal setting exercise. The individual telephone follow-up sessions will occur two weeks after the patient has received his/her CPAP. This session will review CPAP usage and explore barriers and facilitators of CPAP use.
Partners in the Couple-oriented Intervention
n=6 Participants
Partners randomly assigned to the couple-oriented (CO) group will attend two face to face sessions with the patient and participate in an individual telephone follow-up session.
Patients in the Patient-oriented Intervention
n=9 Participants
Patients randomly assigned to the patient-oriented (PT) group will attend two face to face sessions and participate in a telephone follow-up session. Patient-oriented intervention: The first session will occur before the patient receives his/her CPAP. This session will provide the patient with education on sleep apnea and CPAP, demonstration of PAP equipment, explore patient's concerns about starting CPAP treatment, and provide a goal setting exercise. The second face to face session will occur one week after the patient receives his/her CPAP. The second session will provide the patient with information on CPAP usage and pre- and post-treatment AHI, explore barriers to CPAP use and benefits of CPAP use, and provide a goal setting exercise. The telephone follow-up sessions will occur two weeks after the patient has received his/her CPAP. This session will review CPAP usage and explore barriers and facilitators of CPAP use.
Partners in the Patient-oriented Intervention
Partners randomly assigned to the patient-oriented (PT) group will not attend any intervention sessions.
Patients in Usual Care
Patients will not attend any intervention sessions.
Partners in Usual Care
Partners will not attend any intervention sessions.
Continuous Positive Airway Pressure (CPAP) Adherence
1 week
5.6 hours of use
Standard Deviation 2.8
4.5 hours of use
Standard Deviation 2.6
5.8 hours of use
Standard Deviation 2.4
Continuous Positive Airway Pressure (CPAP) Adherence
1 month
6.1 hours of use
Standard Deviation 0.8
5.0 hours of use
Standard Deviation 2.9
5.1 hours of use
Standard Deviation 2.3
Continuous Positive Airway Pressure (CPAP) Adherence
Change from 1 week to 1 month
1.4 hours of use
Standard Deviation 1.9
0.5 hours of use
Standard Deviation 0.8
-0.7 hours of use
Standard Deviation 0.7
Continuous Positive Airway Pressure (CPAP) Adherence
3 months
5.3 hours of use
Standard Deviation 2.9
4.5 hours of use
Standard Deviation 2.8
4.8 hours of use
Standard Deviation 2.4
Continuous Positive Airway Pressure (CPAP) Adherence
Change from 1 month to 3 months
-1.6 hours of use
Standard Deviation 1.8
-0.5 hours of use
Standard Deviation 0.6
-0.3 hours of use
Standard Deviation 1.0

Adverse Events

Patients in the Couple-oriented Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Partners in the Couple-oriented Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Patients in the Patient-oriented Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Partners in the Patient-oriented Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Patients in Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Partners in Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Faith Luyster, PhD

University of Pittsburgh

Phone: 412-624-7910

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place